Aerosolized antibiotics have been shown to be a useful modality of tre
atment in patients with cystic fibrosis. In this investigation we exam
ined the utility of this treatment in patients with other chronic supp
urative lung disorders. These included forty patients, thirty men and
ten women with chronic airway infection (27 with bronchiectasis, 6 wit
h chronic absess and 7 with chronic suppurative bronchitis). Pathogeni
c organisms were isolated from the affected part of the lung by a fibe
roptic bronchoscopy using a sterile disposable bronchial microbiology
brush. Cultures from these specimens were used to determine the approp
riate antibiotic. A second control group of 20 patients was treated wi
th systematic antibiotics alone. Both systemic and aerosolized antibio
tics were administered in 20 patients. A statistically significant imp
rovement in clinical, and ventilatory functions was recorded in the fi
rst group compared to the second. Nebulized antibiotics used as adjunc
tive therapy in association with systemic antibiotics may offer a ther
apeutic advantage in chronic suppurative lung diseases.